Telix Pharmaceuticals Limited Revenue and Competitors

North Melbourne, Australia

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Telix Pharmaceuticals Limited's estimated annual revenue is currently $69.3M per year.(i)
  • Telix Pharmaceuticals Limited's estimated revenue per employee is $155,000

Employee Data

  • Telix Pharmaceuticals Limited has 447 Employees.(i)
  • Telix Pharmaceuticals Limited grew their employee count by 37% last year.

Telix Pharmaceuticals Limited's People

NameTitleEmail/Phone
1
CEO AmericasReveal Email/Phone
2
CEO Telix Asia PacificReveal Email/Phone
3
CFO AmericasReveal Email/Phone
4
CFO EMEAReveal Email/Phone
5
Group Chief Commercial Officer (CCO)Reveal Email/Phone
6
VP MarketingReveal Email/Phone
7
Head Global CommercializationReveal Email/Phone
8
Interim VPReveal Email/Phone
9
VP - Urologic Oncology CommercializationReveal Email/Phone
10
Area VP - Oncology - Central U.S.Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$52.4M33828%N/AN/A
#2
$13.8M899%N/AN/A
#3
$18.6M12021%N/AN/A
#4
$17.1M110-1%N/AN/A
#5
$48.1M3106%N/AN/A
#6
$15.3M9927%N/AN/A
#7
$13.6M88-14%N/AN/A
#8
$15.5M1009%N/AN/A
#9
$19.7M1278%N/AN/A
#10
$21.2M137-4%$33.8MN/A
Add Company

What Is Telix Pharmaceuticals Limited?

Telix is a biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, and the United States. Telix is developing a portfolio of clinical-stage products that address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX).

keywords:N/A

N/A

Total Funding

447

Number of Employees

$69.3M

Revenue (est)

37%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Telix Pharmaceuticals Limited News

2022-04-19 - Telix Further Strengthens European Distribution Network for ...

MELBOURNE, Australia and LIÈGE, Belgium, April 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today...

2022-04-06 - (PRNewsfoto/Telix Pharmaceuticals Limited ...

MELBOURNE, Australia and INDIANAPOLIS, March 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the...

2022-04-06 - Telix Pharmaceuticals Announces Licence Agreement with ...

MELBOURNE, Australia and INDIANAPOLIS, April 10, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, "Telix", the "Company") today...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$69.3M44737%N/A
#2
$114.8M4572%N/A
#3
$159.4M9496%N/A
#4
$279.1M9922%N/A